Hematopoietic stem cell transplantation (HSCT) is an established therapeutic intervention for a variety of haematological malignancies and non-malignant disorders. Central to the success of HSCT is ...
Ultrahigh resolution (UHR) HLA matching is reported to result in better outcomes following unrelated donor hematopoietic cell transplantation, improving survival and reducing post-transplant ...
Please provide your email address to receive an email when new articles are posted on . For years, hematopoietic stem cell transplantation physicians have viewed a matched unrelated donor as the gold ...
ORLANDO -- Stem-cell transplants with mismatched unrelated donors (MMUDs) beyond a single HLA locus (<7/8) had 1-year survival similar to better-matched donors, suggesting significant potential to ...
Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors The study included 17,292 unrelated ...
Jayme Locke, MD MARCO ISLAND, Fla.—The transplant community may want to rethink the importance of HLA mismatches when considering live donor kidney transplants, according to new data presented here at ...
Allogeneic hematopoietic stem cell transplantation is a curative treatment for severe aplastic anemia, but selecting the best donor remains a critical and sometimes difficult decision for clinicians.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results